Moses Jennifer K. 4
4 · G1 Therapeutics, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Moses Jennifer K.
VP of Finance & Admin
Transactions
- Award
Common Stock
2021-01-04+11,000→ 22,000 total - Award
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 totalExercise: $18.07Exp: 2031-01-04→ Common Stock (58,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents 11,000 shares of common stock and 11,000 restricted stock units.
- [F4]The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.